Keywords: Sanofi, Genzyme, First-quarter 2012 financial results
Sanofi's strong 1st-qtr driven by Genzyme
Article | 27 April 2012
French drug major Sanofi (Euronext: SAN) posted a strong set of first-quarter 2012 financial results this morning, with group turnover rising 9.4% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
